Treatment Effectiveness
User reported effectiveness ratings Citalopram (Celexa) for various conditions.
| Conditions | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Menopause | 0% | 33% | 0% | 33% | 33% | 3 |
Side Effects
User-reported side effects of Citalopram (Celexa)
| Side Effect | Percent of Reports Citalopram (Celexa) |
|---|---|
| Nervousness | 28% |
| Diarrhea | 16% |
| Dry Mouth | 35% |
| Stomach Pain | 14% |
| Changes in Sex Drive or Ability | 53% |
| Drowsiness | 37% |
| Excessive Sweating | 18% |
| Excessive Tiredness | 38% |
| Excitement | 15% |
| Loss of Appetite | 20% |
| Muscle or Joint Pain | 13% |
| Uncontrollable Shaking of a Part of the Body | 15% |
| Vomiting | 7% |
| Headache | 100% |
| Nausea | 31% |
Outcomes
Below is the degree of change seen after Citalopram (Celexa) is higher than average.
|
|
Don't see what you're looking for?
Create a study and help us eradicate suffering!
Daily Distribution
Average by Year
Average by Month
Average by Day of Week
Outcomes Label
Citalopram (Celexa) Info
| Property | Value |
|---|---|
| Variable Name | Citalopram (Celexa) |
| Aggregation Method | SUM |
| Analysis Performed At | 2020-10-09 |
| Duration of Action | 21 days |
| Filling Value | 0 |
| Kurtosis | 57.05 |
| Mean | 0.5083335 count |
| Median | 0.5 count |
| Minimum Allowed Value | 0 count |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 2 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 2 |
| Public | true |
| Onset Delay | 30 minutes |
| Standard Deviation | 0.06454972243679 |
| Unit | Count |
| User Variables | 2 |
| UPC | 852181008012 |
| Variable Category | Treatments |
| Variable ID | 92914 |
| Variance | 0.0083333333333334 |